22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities

BUFFALO, N.Y., July 01, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused

Read more